NASDAQ: CNAT       Conatus Pharmaceutic
Last Price Today's Change   Day's Range   Trading Volume
0.00   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):0
52 Weeks Range:0.23 - 0.75
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Conatus Pharmaceuticals Inc is a biotechnology company. It focuses on the development and commercialization of novel medicines to treat liver disease. The company is developing emricasan, an orally active pan-caspase protease inhibitor, for the treatment of patients with the chronic liver disease. Its operations are divided into only one reportable segment, which is the commercialization and development of pharmaceutical products.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3624  2328  299  3151 

Top 10 Active Counters
 LK 1.38+1.38 
 NIO 30.975+3.465 
 NOK 3.34-0.71 
 PINS 63.76+14.51 
 F 7.915+0.215 
 GE 7.415-0.005 
 OAS 0.155-0.014 
 AAPL 115.981+4.781 
 POLA 3.33+1.00 
 SQQQ 23.081-1.569